2001
DOI: 10.1007/s005400170050
|View full text |Cite
|
Sign up to set email alerts
|

A possible role for glutamate receptor-mediated excitotoxicity in chronic pain

Abstract: brainstem and targeting pain transmission within the dorsal horn. Significant progress has been made in the study of pain-modulating networks. However, little is understood regarding the spinal circuits through which descending pain modulatory neurons exert their effects. With recent insight into the pharmacology of different neural circuits, the importance of spinal mechanisms of descending modulation in the response of the nervous system to persistent pain after injury is being reevaluated.Evidence that desc… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2014
2014
2023
2023

Publication Types

Select...
4

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(1 citation statement)
references
References 96 publications
0
1
0
Order By: Relevance
“…The mGluRs function in two ways, by directly increasing cytosolic Ca 2+ levels via the facilitation of Ca 2+ release from the intracellular stores, and indirectly by promoting NMDA receptor migration to the cell membrane [ 27 ]. Excitotoxicity is one of the leading causes of neuronal damage and death, and this process has been implicated in a variety of neurological diseases including schizophrenia, Alzheimer’s, Parkinson’s, multiple sclerosis (MS), epilepsy, chronic pain, and migraine [ 28 , 29 , 30 , 31 , 32 , 33 ].…”
Section: Glutamatergic Neurotransmissionmentioning
confidence: 99%
“…The mGluRs function in two ways, by directly increasing cytosolic Ca 2+ levels via the facilitation of Ca 2+ release from the intracellular stores, and indirectly by promoting NMDA receptor migration to the cell membrane [ 27 ]. Excitotoxicity is one of the leading causes of neuronal damage and death, and this process has been implicated in a variety of neurological diseases including schizophrenia, Alzheimer’s, Parkinson’s, multiple sclerosis (MS), epilepsy, chronic pain, and migraine [ 28 , 29 , 30 , 31 , 32 , 33 ].…”
Section: Glutamatergic Neurotransmissionmentioning
confidence: 99%